Skip to main content
Smart Investors Daily
Bullfrog AI Holdings, Inc. Common Stock logo

NASDAQ · BFRG

Bullfrog AI Holdings, Inc. Common Stock

Healthcare · Medical - Healthcare Information Services

$0.52

Up+$0.03 (+5.40%)

Updated Nov 4, 2026, 8:03 AM

SID Score

2.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
11.08M
P/E ratio
-1.76
Dividend yield
0.00%
52-week range
$0.43 – $1.96
Volume
204.11K
Avg. volume
228.81K

Price performance · BFRG

BFRG price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

BFRG closed at $0.52 after 21 trading sessions, down 24.06% for the selected period.

Last close
$0.52
Period change
-24.06%
Period low
$0.48
Period high
$0.71
Daily close
View OHLC price history
BFRG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$0.5037$0.53$0.4974$0.5232204.11K
Nov 2, 2026$0.4917$0.52$0.4818$0.4964156.97K
Oct 30, 2026$0.4908$0.4994$0.4756$0.4877125.19K
Oct 29, 2026$0.499$0.519$0.49$0.506157.32K
Oct 28, 2026$0.469$0.4989$0.4645$0.487193.71K
Oct 27, 2026$0.4814$0.4841$0.46$0.4752186K
Oct 26, 2026$0.49$0.50$0.4732$0.481118.32K
Oct 23, 2026$0.4885$0.5067$0.48$0.4938107.44K
Oct 22, 2026$0.5008$0.5149$0.4836$0.4932168.92K
Oct 21, 2026$0.509$0.5298$0.495$0.5163212.91K
Oct 20, 2026$0.5348$0.5448$0.4888$0.4919318.44K
Oct 19, 2026$0.535$0.555$0.5066$0.5272201.4K
Oct 16, 2026$0.559$0.56$0.5035$0.5128264.24K
Oct 15, 2026$0.5128$0.56$0.5025$0.5348337.3K
Oct 14, 2026$0.5518$0.5638$0.5138$0.5323347.54K
Oct 13, 2026$0.588$0.588$0.5478$0.5689319.82K
Oct 12, 2026$0.625$0.6798$0.5813$0.5838403.99K
Oct 9, 2026$0.676$0.70$0.6198$0.646584.36K
Oct 8, 2026$0.71$0.7565$0.67$0.69241.37M
Oct 7, 2026$0.7945$0.83$0.6569$0.708625.19M
Oct 6, 2026$0.586$0.7141$0.5444$0.68937.77M

Latest BFRG news

The latest Smart Investors Daily articles mentioning BFRG.

BFRG research

Overview

Company profile and research snapshot.

Company profile

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 27, 2026

BullFrog AI Founder and CEO Vin Singh to Deliver Keynote at AIDDD Summit

Keynote to explore the progress and remaining challenges of AI in drug discovery and developmentGAITHERSBURG, Md., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI"), an AI company using its proprietary platform to turn complex biomedical data into actionable insights, today announced that Vin Singh, Founder and Chief Executive Officer, will deliver the keynote at the AI Drug Discovery & Development (“AIDDD”) Summit today, October 27, 2026, at 5:30

Yahoo · Oct 13, 2026

BullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026

GAITHERSBURG, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), an AI company using its proprietary platform to turn complex biomedical data into actionable insights, today announced Vin Singh, Founder and Chief Executive Officer, will participate in the 20th Annual LD Micro Main Event being held October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Mr. Singh is scheduled to present to investors on Tuesd

Yahoo · Oct 6, 2026

BullFrog AI Advances Major Depressive Disorder Drug Discovery Program With Global Pharma Partner

BullFrog AI has reached key milestones in its first commercial project with a top-five global pharmaceutical company, identifying and prioritising novel therapeutic targets for major depressive disorder using its AI platform. Key Investor TakeawaysBullFrog AI (NASDAQ:BFRG) said it successfully identified and prioritised novel therapeutic targets for major depressive disorder under its commercial pharmaceutical program.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.